EmailHospital Circular 25/2011
Date Issued: 11 November 2011
Distribution: Public Hospitals, Private Hospitals
Subject: Direct Order - Intravenous Immunoglobulin (IVIg)
Purpose: To advise hospitals of updated arrangements for Direct Order of Intravenous Immunoglobulin (IVIg).
Background
This circular:
- Updates the “Alternative Access to IVIg – Jurisdictional Direct Orders (JDO)” notified in Circular 8/2008 available at http://www.health.vic.gov.au/hospitalcirculars/circ08/circ0808.htm
- Replaces the circular “Direct Order – Intravenous Immunoglobulin (IVIg)” Hospital Circular 06/2010 at http://www.health.vic.gov.au/hospitalcirculars/circ10/circ0610.htm
Direct Order - Intravenous Immunoglobulin (IVIg)
Patients requiring IVIg for conditions that do not meet the ‘Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg) in Australia’ (the Criteria) will not have the IVIg subsidised under the National Blood Agreement. The Criteria can be found at: http://www.nba.gov.au/ivig/index.html
The National Blood Authority has arrangements with three companies to facilitate the purchase of IVIg for the treatment of conditions not satisfying the Criteria, the Baxter product will not be available under these arrangements until 1 January 2012.
| Supplier | Distributor | Phone | Fax | |
|---|---|---|---|---|
| Octapharma Australia | DHL Exel | 1800 077 421 | 1800 358 199 | pharmacysupplycs@dhl.com |
| Grifols Australia Pty Ltd | Grifols Australia Pty Ltd | 03 9535 9333 | 03 9535 9300 | orders@lateralgrifols.com |
| Baxter Healthcare Pty Ltd | Baxter Healthcare | 1300 789 646 | 1300 659 877 | Australia_shs_customer_support@baxter.com |
Maree Guyatt
Director
Integrated Care
